Literature DB >> 19136527

Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy.

C-H Liu, C-C Liang, C-J Liu, H-B Tsai, P-H Hung, S-J Hsu, S-I Chen, J-W Lin, M-Y Lai, J-H Chen, P-J Chen, D-S Chen, J-H Kao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19136527     DOI： 10.1136/gut.2008.165076

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

Review 1.  Hepatitis C in hemodialysis patients.

Authors:  Smaragdi Marinaki; John N Boletis; Stratigoula Sakellariou; Ioanna K Delladetsima
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Hepatic disorders in chronic kidney disease.

Authors:  Fabrizio Fabrizi; Piergiorgio Messa; Carlo Basile; Paul Martin
Journal:  Nat Rev Nephrol       Date:  2010-04-13       Impact factor: 28.314

3.  Ribavirin-induced anaemia reduced tacrolimus level in a hepatitis C patient receiving haemodialysis.

Authors:  Hin-Yee Liu; Catherine Yuen Shan Cheung; Susan Elizabeth Cooper
Journal:  BMJ Case Rep       Date:  2018-04-18

Review 4.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Roberto J Carvalho-Filho; Ana Cristina C A Feldner; Antonio Eduardo B Silva; Maria Lucia G Ferraz
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

5.  Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients.

Authors:  Chen-Hua Liu; Cheng-Chao Liang; Kai-Wen Huang; Chun-Jen Liu; Shih-I Chen; Jou-Wei Lin; Peir-Haur Hung; Hung-Bin Tsai; Ming-Yang Lai; Pei-Jer Chen; Jun-Herng Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-10       Impact factor: 8.237

6.  APASL consensus statements and management algorithms for hepatitis C virus infection.

Authors:  Masao Omata; Tatsuo Kanda; Ming-Lung Yu; Osamu Yokosuka; Seng-Gee Lim; Wasim Jafri; Ryosuke Tateishi; Saeed S Hamid; Wan-Long Chuang; Anuchit Chutaputti; Lai Wei; Jose Sollano; Shiv Kumar Sarin; Jia-Horng Kao; Geoffrey W McCaughan
Journal:  Hepatol Int       Date:  2012-03-01       Impact factor: 9.029

Review 7.  Hepatitis C virus infection and dialysis: 2012 update.

Authors:  Fabrizio Fabrizi
Journal:  ISRN Nephrol       Date:  2012-12-17

Review 8.  Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review.

Authors:  Jonathan Aguirre Valadez; Ignacio García Juárez; Rodolfo Rincón Pedrero; Aldo Torre
Journal:  Ther Clin Risk Manag       Date:  2015-02-27       Impact factor: 2.423

Review 9.  Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.

Authors:  Chen-Hua Liu; Jia-Horng Kao
Journal:  Int J Nanomedicine       Date:  2014-04-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.